量子力学/分子力学计算反应性网络揭示了细胞染色体P450cam及其T252A突变物如何选择其氧化途径
Binju Wang1, Chunsen Li2,3, Kshatresh Dutta Dubey1
1†Institute of Chemistry and The Lise Meitner-Minerva Center for Computational Quantum Chemistry, The Hebrew University of Jerusalem, 91904 Jerusalem, Israel.
Journal of the American Chemical Society
|May 27, 2015
概括
量子力学/分子力学计算揭示了P450酶的新催化途径,排除了"第二氧化剂",并解释了T252A突变体对基质的特定环氧化.
科学领域:
- 生物化学和酶学 生物化学和酶学
- 计算化学的计算化学
- 结构生物学 结构生物学
背景情况:
- 细胞P450酶催化了关键的氧化反应.
- 450催化机制,特别是化合物I (Cpd I) 的作用,已被广泛研究.
- 研究了P450cam中的一个突变 (Threonine-252-to-Alanine,T252A),以了解质子穿的作用.
研究的目的:
- 为了调查长期存在的关于P450酶中的"第二氧化剂"的问题.
- 为了阐明P450cam T252A突变的催化机制.
- 为了确定由T252A突变体对5-甲基甲氧化过程负责的途径.
主要方法:
- 使用量子力学/分子力学 (QM/MM) 计算.
- 通过研究氧化剂候选物:Cpd I,铁氧化物和铁过氧化物 (Fe (III) (O2H2)) 的反应性网络.
- 分析了基质和蛋白质相互作用在稳定中间体中的作用.
主要成果:
- 确定了一个"第二合路径",由Fe (III) (O2H2) 介质启动.
- 这一途径涉及O-O同解和H-抽象,导致Cpd I的形成.
- 基质 (5-甲基) 和蛋白质的相互作用决定了Fe (III) (O2H2) 的持久性和反应性,影响了环氧化,并阻止了的氧化.
结论:
- 该研究排除了"第二氧化剂",并确定了P450cam.cam中的额外合途径.
- 在T252A突变使一个新的途径涉及Fe (III) (O2H2) 进行基质环氧化.
- 结果导致了对cytochrome P450cam的修订后的催化循环,突出了基质-蛋白相互作用.
相关概念视频
Drug Metabolism: Phase I Reactions
5.8K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.8K
Electron Transport Chain: Complex III and IV
9.8K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.8K
Electron Transport Chain: Complex I and II
19.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.7K
Bioactivation and Tissue Toxicity
131
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
131
Photochemical Electrocyclic Reactions: Stereochemistry
2.4K
The absorption of UV–visible light by conjugated systems causes the promotion of an electron from the ground state to the excited state. Consequently, photochemical electrocyclic reactions proceed via the excited-state HOMO rather than the ground-state HOMO. Since the ground- and excited-state HOMOs have different symmetries, the stereochemical outcome of electrocyclic reactions depends on the mode of activation; i.e., thermal or photochemical.
Selection Rules: Photochemical Activation
Selection Rules: Photochemical Activation
2.4K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
218
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
218


